Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nickel Catalyzed Cross Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1289190C details a novel Ni-catalyzed cross-coupling process eliminating cryogenic conditions, offering significant cost reduction and supply chain reliability for high-purity aryl compounds.
Patent CN113480416A details a mild, nickel-catalyzed route for aryl ketones, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN116283515A reveals a direct cross-coupling method using aryl fluorides and bromides. This technology offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Novel Ni-catalyzed difluoroalkylation offers mild conditions and cost efficiency for high-purity isoquinoline-1,3-dione manufacturing.
Novel nickel-catalyzed route for a-BPDA production offers significant cost reduction and simplified processing for high-performance polyimide manufacturing supply chains.
Patent CN113461646A details a nickel-catalyzed route for 3,4'-BPDA. It offers significant cost reduction and simplified separation for high-purity polyimide monomers.
Patent CN100465139C reveals a高效 nickel-catalyzed coupling method for tetramethylbiphenyl, offering significant cost reduction and simplified processing for polyimide manufacturing supply chains.
Patent CN110981900A reveals a novel nickel-catalyzed method for synthesizing 1,1-diyne compounds from terminal olefins, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1466487A details a safe nickel-catalyzed cross-coupling process eliminating cryogenic conditions, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN109608380B reveals a high-yield Nickel-catalyzed route for Bromfenac intermediates, offering significant cost reduction and supply chain reliability for global pharma manufacturers.
Patent CN107118143A reveals nickel-catalyzed synthesis offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN114832862A reveals a cost-effective nickel-catalyzed route for fluorinated isoquinoline-1,3-diones, offering significant supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Patent CN118307453A details a nickel-catalyzed route for alkylaryl sulfoxides, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Novel nickel-catalyzed direct cross-coupling of aryl fluorosulfates and bromides. Reduces steps, avoids toxic reagents. Reliable pharma intermediate supplier.
Patent CN114874127B details a cost-effective nickel-catalyzed method for difluorocarbonylated indolones, offering significant supply chain and purity advantages.
Patent CN103086850A reveals a novel Ni-catalyzed route for CF2O-containing compounds, offering significant cost reduction in electronic chemical manufacturing and improved scalability.
Novel Ni-catalyzed desulfitative coupling of sulfonyl chlorides offers high yield and broad scope. A cost-effective route for API intermediates and fine chemicals.
Novel Ni-catalyzed method for trifluoroethylation using cheap 2-chloro-1,1,1-trifluoroethane. Mild conditions, high yield, suitable for pharma intermediates.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.